- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Acute Myeloid Leukemia (AML) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Acute Myeloid Leukemia (AML) Therapeuticsmarket, defines the market attractiveness level of Acute Myeloid Leukemia (AML) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Acute Myeloid Leukemia (AML) Therapeutics industry, describes the types of Acute Myeloid Leukemia (AML) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acute Myeloid Leukemia (AML) Therapeutics market and the development prospects and opportunities of Acute Myeloid Leukemia (AML) Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acute Myeloid Leukemia (AML) Therapeutics market in Chapter 13.
By Player:
GlaxoSmithKline Pharmaceuticals
Bristol-Myers Squibb
Novartis
Genmab
Roche
By Type:
Chemotherapy
Radiation therapy
Stem Cell Transplant
Targeted Therapy
Others
By End-User:
Hospital
Retails Drug Stores
Ambulatory Care Centers
Oncology Centers
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Acute Myeloid Leukemia (AML) Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Acute Myeloid Leukemia (AML) Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Acute Myeloid Leukemia (AML) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Acute Myeloid Leukemia (AML) Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Acute Myeloid Leukemia (AML) Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Acute Myeloid Leukemia (AML) Therapeutics Consumption (2017-2022)
-
7.2 United States Acute Myeloid Leukemia (AML) Therapeutics Consumption (2017-2022)
-
7.3 Europe Acute Myeloid Leukemia (AML) Therapeutics Consumption (2017-2022)
-
7.4 China Acute Myeloid Leukemia (AML) Therapeutics Consumption (2017-2022)
-
7.5 Japan Acute Myeloid Leukemia (AML) Therapeutics Consumption (2017-2022)
-
7.6 India Acute Myeloid Leukemia (AML) Therapeutics Consumption (2017-2022)
-
7.7 South Korea Acute Myeloid Leukemia (AML) Therapeutics Consumption (2017-2022)
8 Region and Country-wise Acute Myeloid Leukemia (AML) Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast (2022-2028)
9 Global Acute Myeloid Leukemia (AML) Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Acute Myeloid Leukemia (AML) Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Radiation therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Stem Cell Transplant Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Acute Myeloid Leukemia (AML) Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retails Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ambulatory Care Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Oncology Centers Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Acute Myeloid Leukemia (AML) Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Radiation therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Stem Cell Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retails Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ambulatory Care Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Oncology Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Acute Myeloid Leukemia (AML) Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Acute Myeloid Leukemia (AML) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Acute Myeloid Leukemia (AML) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Acute Myeloid Leukemia (AML) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Acute Myeloid Leukemia (AML) Therapeutics Market Competitive Analysis
-
14.1 GlaxoSmithKline Pharmaceuticals
-
14.1.1 GlaxoSmithKline Pharmaceuticals Company Details
-
14.1.2 GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Acute Myeloid Leukemia (AML) Therapeutics Product and Service
-
14.4 Genmab
-
14.4.1 Genmab Company Details
-
14.4.2 Genmab Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Genmab Acute Myeloid Leukemia (AML) Therapeutics Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche Acute Myeloid Leukemia (AML) Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Acute Myeloid Leukemia (AML) Therapeutics
-
Figure Acute Myeloid Leukemia (AML) Therapeutics Picture
-
Table Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Consumption by Country (2017-2022)
-
Figure United States Acute Myeloid Leukemia (AML) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Acute Myeloid Leukemia (AML) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Acute Myeloid Leukemia (AML) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Acute Myeloid Leukemia (AML) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Acute Myeloid Leukemia (AML) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Acute Myeloid Leukemia (AML) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Stem Cell Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Retails Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Care Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stem Cell Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retails Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Care Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Acute Myeloid Leukemia (AML) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Acute Myeloid Leukemia (AML) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Acute Myeloid Leukemia (AML) Therapeutics Product and Service
-
Table Genmab (Foundation Year, Company Profile and etc.)
-
Table Genmab Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genmab Acute Myeloid Leukemia (AML) Therapeutics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Acute Myeloid Leukemia (AML) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Acute Myeloid Leukemia (AML) Therapeutics Product and Service
-